![Sean Gaskell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sean Gaskell
Directeur Technique/Scientifique/R&D chez Alvotech hf
Profil
Sean Gaskell is currently the Chief Technical Officer at Alvotech hf.
Prior to his current position, he held the role of Vice President-Manufacturing Operations at Novartis Gene Therapies, Inc. from 2018 to 2020.
He also served as the Site Head at Novartis AG.
Dr. Gaskell has a background in undergraduate and doctorate studies from Loughborough University.
Postes actifs de Sean Gaskell
Sociétés | Poste | Début |
---|---|---|
Alvotech hf
![]() Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Directeur Technique/Scientifique/R&D | 01/05/2020 |
Anciens postes connus de Sean Gaskell
Sociétés | Poste | Fin |
---|---|---|
AVEXIS INC | Corporate Officer/Principal | 01/01/2020 |
NOVARTIS AG | Corporate Officer/Principal | - |
ALVOTECH | Directeur Technique/Scientifique/R&D | - |
Formation de Sean Gaskell
Loughborough University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ALVOTECH | Health Technology |
NOVARTIS AG | Health Technology |
Entreprise privées | 2 |
---|---|
Novartis Gene Therapies, Inc.
![]() Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Alvotech hf
![]() Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |